Chronic diseases are not being managed effectively in either high-risk or low-risk populations in South Africa

Brand, Martin; Woodiwiss, Angela J.; Michel, Fabrice; Booysen, Hendrik L.; Majane, Olebogeng H.I.; Maseko, Muzi J.; Veller, Martin; Norton, Gavin R.

doi:10.7196/samj.6018

Cited by 4 publications

(3 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In South Africa, NCDs are estimated to account for 51% of all deaths (World Health Organization, 2018) and are a leading cause of premature mortality (Nojilana et al, 2016). The increased prevalence of NCDs across the country has placed enormous pressure on both public and private health care facilities (Mayosi et al, 2009), resulting in reports of poor management of chronic diseases in the public health care system (Brand et al, 2013). The South African government has introduced several policies aimed at reducing NCDs through prevention, monitoring, and management (more than 40 policies between 1994 and 2015), for example, the 1993-Tobacco Products Control Act 21, the 2013 Salt Reduction Regulations, and the 2015 Strategy for Tackling Obesity.…”

Section: Why Do We Need To Prioritise Health Psychology Now?mentioning

confidence: 99%

Re-visiting the relevance and importance of health psychology in South Africa

Coetzee

Vogel

Sander

et al. 2022

South African Journal of Psychology

View full text Add to dashboard Cite

Health psychology as a discipline has existed for more than four decades and is primarily concerned with research, theory, and practice at the nexus of psychology and health. The discipline is well established across Europe, the United States, and Australia with health psychology societies, postgraduate programmes, conferences, and academic journals dedicated to the discipline in the majority of these countries. However, in South Africa, health psychology remains a broad umbrella term under which psychologists and other health care professionals conduct research. Health psychology is concerned with the biological, social, psychological, contextual, and structural drivers of health and illness, and relies on theory and empirically-driven research to identify and understand important links between health and behaviour. In South Africa, where a large proportion of the population faces multiple co-occurring disease epidemics, such as HIV/AIDS, TB, COVID-19, diabetes, and heart disease, there is a need for a uniting sub-discipline like health psychology to focus intervention efforts and to meet the sustainable development goals. The recent re-establishment of a special interest group in health psychology in the Psychological Society of South Africa (PsySSA) is an important first step. In this article, and as members of the newly re-established special interest group in health psychology, we call attention to the need to promote health psychology in South Africa. In this article, we describe the paradigmatic traditions and theoretical models that inform the discipline. We then argue why health psychology should be prioritised again and recommend future directions for health psychology in South Africa.

show abstract

Section: Why Do We Need To Prioritise Health Psychology Now?mentioning

confidence: 99%

Re-visiting the relevance and importance of health psychology in South Africa

Coetzee

Vogel

Sander

et al. 2022

South African Journal of Psychology

View full text Add to dashboard Cite

show abstract

“…Despite the introduction of this approach the disease incidence and prevalence in developing countries is increasing. This calls for action to increase the detection rate, prevention and treatment options (1,2).…”

Section: Introductionmentioning

confidence: 99%

Cost-effectiveness of Comprehensive screening of general population for hypertension: Can it save money and Life? Systematic review of Pharmacoeconomic Studies

Davari¹,

Sorato²,

Nikfar³

2020

Preprint

View full text Add to dashboard Cite

Background: Hypertension is one of major modifiable risk factors contributing for development of ischemic heart disease, diabetes, kidney disease, cerebrovascular disease and peripheral arterial disease. Silent nature of the disease, delayed presentation of patients to health system after development of significant cardiovascular events and poor access to comprehensive health care are major challenge of hypertension control. Early screening, detection and treatment of hypertension is effective for control of the disease progression. However, there is no robust evidence on whether screening general population for hypertension is cost-effective or not. Therefore, this review was conducted t o generate evidence on cost effectiveness of population-based hypertension screening for asymptomatic individuals as early detection strategy for the primary prevention of cardiovascular diseases. Methods: PubMed/Medline , Scopus, Web of sciences and Google Scholar were searched from January 2000 to 11 December 2019. Two investigators independently selected and reviewed fair and good-quality pharmacoeconomic studies for the cost-effectiveness of asymptomatic screening for hypertension in the community. Quality of selected literatures are evaluated by authors based on comprehensive tool developed for critical appraisal of pharmacoeconomic studies. Results: Eleven included Pharmacoeconomic studies reported favorable results for screening asymptomatic adults for hypertension. Most of studies agreed on cost-effectiveness of screening adults aged 40 years and older. Screening of general adult population for hypertension is not-cost effective. Conclusion: Screening population 40 years and older with or without additional risk factors is cost-effective in reducing hypertension and associated cardiovascular disease morbidity and mortality in developed and developing countries.

show abstract

“…[6] A large percentage of SA vascular patients have mean blood pressures above the therapeutic target. [7] Acknowledging that poorly controlled hypertension is highly prevalent in the SA vascular patient population, it is possible that uncontrolled hypertension could further aggravate haemodynamic instability caused by acute β-blockade, resulting in high levels of perioperative cardiac morbidity and mortality.…”

mentioning

confidence: 99%